Thursday 30 October, Riyadh – CSL Seqirus and Vaccine Industrial Company, have signed a Memorandum of Understanding with the Ministry of Health of Saudi Arabia to enhance the biotechnology sector by accessing advanced cell-based seasonal and pandemic influenza vaccines and localizing manufacturing in Saudi Arabia. Under a finalised agreement, CSL Seqirus, a leading global influenza vaccine...
The construction of the Kingdom’s pioneering human vaccine manufacturing facility continues to progress ahead of schedule, marking a new chapter in Saudi Arabia’s biotechnology ambitions. A new video released today showcases the latest advancements at the factory site, reflecting rapid development and commitment to excellence. Dr. Khaled Almosa, founder of Saudi Bio, the Vaccine Industrial...
Dr. Khaled Al-Mousa, founder of Saudi Bio and founder of the vaccine manufacturing company, explained via a tweet on his account on the X platform that construction work on the human vaccine factory began at the beginning of this year. This factory is considered the first of its kind in the Kingdom and the largest...
We are thrilled to announce that Vaccine Research, Development, and Innovation Co. (Vaccine RDI) has signed a Memorandum of Understanding (MoU) with the esteemed King Abdulaziz City for Science and Technology (KACST). This landmark partnership, sealed on October 22, 2024, marks a new chapter in advancing scientific research, technological innovation, and pharmaceutical development....
We are excited to announce the release of our new company introduction video, now available on our media page. This video provides an insightful look into our mission, values, and our role as a leading manufacturer of vaccines in the Kingdom of Saudi Arabia. Watch the video to learn more about our journey, our commitment...
Under the esteemed patronage of His Excellency the Irish Ambassador and representatives of the Irish government, a significant milestone in the biotechnology and vaccine manufacturing sector was achieved today at the Irish Embassy. A project management agreement was officially signed between VACCINE INDUSTRIAL COMPANY (VIC) the largest vaccine manufacturer in the Middle East, Modon-Sudair, and...
SAR500m facility in Sudair City To produce vaccines and medicines Pharma worth $19.8bn by 2032 Saudi Arabia is planning to invest SAR500 million ($133 million) in a factory to boost local vaccine and medicine manufacturing capacity as the kingdom seeks to become a regional centre for biotechnology. Saudi Authority for Industrial Cities and Technology Zones,...
VCRDI and Baylor College of Medicine (BCM) have signed Academic and R&D agreement for vaccine development. VCRDI and BCM have singed a training agreement to train VCRDI scientists in vaccine development, including scale-up process development, quality control testing, formulation technology, and regulatory documentation. The Training Program will be conducted at BCM’s facilities (Center for Vaccine...
Vaccine industrials company and Saudi authority for industrial cities and technology zone (modon) have signed land allocation agreement with an area of 42 thousand and square meters to establish vaccines manufacturing facility in sudair industrial city, Saudi Arabia.
Saudi Authority for Industrial Cities and Technology Zones (MODON) has signed a SR500m ($133m) investment agreement with the Vaccine Industrial Company (Vaccine) to set up a joint venture factory in Sudair City to strengthen the pharmaceutical security system and localise the manufacturing of vaccines and vital medicines in the Kingdom. This agreement comes in line...
